Literature DB >> 33201428

Pre-exposure Prophylaxis (PrEP) Awareness and Prescribing Behaviors Among Primary Care Providers: DocStyles Survey, 2016-2020, United States.

Jamal T Jones1, B Rey deCastro2, Euna M August2, Dawn K Smith2.   

Abstract

Few studies have assessed providers' intent of prescribing PrEP in the future. We analyzed cross-sectional web-based surveys to estimate trends from 2016 to 2020 in PrEP awareness and prescribing behaviors in the United States among primary care providers. Multivariable logistic regression was used to estimate prevalence of PrEP awareness, prescribing behaviors, and likelihood of prescribing PrEP in the next 12 months. The adjusted prevalence for PrEP awareness was significantly higher in 2019 (93.7%, 95% CI 91.9%, 95.2%) compared to 2018 (88.1%, 95% CI 85.5%, 90.3%). The adjusted prevalence for prescribing PrEP was significantly higher in 2019 (16.4%, 95% CI 13.6%, 19.6%) and 2020 (15.6%, 95% CI 13.0%, 18.7%) compared to 2018 (12.2%, 95% CI 10.0%, 14.7%). Practicing in the West and regularly screening for HIV were associated with higher PrEP awareness and provision. Studies should examine factors associated with PrEP provision for groups with increased risk for HIV.

Entities:  

Keywords:  Awareness; HIV prevention; Patient groups; Pre-exposure prophylaxis; Provision

Mesh:

Substances:

Year:  2020        PMID: 33201428     DOI: 10.1007/s10461-020-03089-5

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  1 in total

1.  Access to healthcare, HIV/STI testing, and preferred pre-exposure prophylaxis providers among men who have sex with men and men who engage in street-based sex work in the US.

Authors:  Kristen Underhill; Kathleen M Morrow; Christopher M Colleran; Richard Holcomb; Don Operario; Sarah K Calabrese; Omar Galárraga; Kenneth H Mayer
Journal:  PLoS One       Date:  2014-11-11       Impact factor: 3.240

  1 in total
  4 in total

1.  Examining HIV Diagnosis and Linkage to PrEP Prescription Among Members at An Integrated Health System in the Southeast United States.

Authors:  Teaniese L Davis; Mona Mittal; Adanna C Oragwu; Min Qi Wang; Bradley O Boekeloo
Journal:  AIDS Behav       Date:  2022-09-12

2.  Exploring Awareness, Perceptions, and Willingness to Use HIV Pre-Exposure Prophylaxis: A Qualitative Study of Ghanaian Immigrants in the United States.

Authors:  Gloria Aidoo-Frimpong; Heather Orom; Kafuli Agbemenu; R Lorraine Collins; Gene D Morse; LaRon E Nelson
Journal:  AIDS Patient Care STDS       Date:  2021-12-15       Impact factor: 5.944

3.  Financing and Delivering Pre-Exposure Prophylaxis (PrEP) to End the HIV Epidemic.

Authors:  Amy Killelea; Jeremiah Johnson; Derek T Dangerfield; Chris Beyrer; Matthew McGough; John McIntyre; Rebekah E Gee; Jeromie Ballreich; Rena Conti; Tim Horn; Jim Pickett; Joshua M Sharfstein
Journal:  J Law Med Ethics       Date:  2022       Impact factor: 1.604

4.  Evidence of Potential Discriminatory HIV Pre-Exposure Prophylaxis (PrEP) Prescribing Practices for People Who Inject Drugs Among a Small Percentage of Providers in the U.S.

Authors:  Benedikt Pleuhs; Colleen B Mistler; Katherine G Quinn; Julia Dickson-Gomez; Jennifer L Walsh; Andrew E Petroll; Steven A John
Journal:  J Prim Care Community Health       Date:  2022 Jan-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.